Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
SAKAR

Sakar Healthcare Share Price

 
Stock is trading on High Volume

 

Sakar Healthcare live price: ₹696.7. It opened at ₹600 vs previous close ₹600; intraday high/low: ₹710/₹587. The 50 & 200 DMA stand at ₹564.72/₹454.47.

Sakar Healthcare Performance

  • Today's Low
  • ₹587
  • Today's High
  • ₹710
  • 52 Week Low
  • ₹305
  • 52 Week High
  • ₹710
  • Open Price₹600
  • Previous Close₹600
  • Volume1,165,334
  • 50 DMA₹564.72
  • 100 DMA₹514.76
  • 200 DMA₹454.47

Sakar Healthcare Chart

Investment Returns

  • Over 1 Month + 18.03%
  • Over 3 Month + 51.19%
  • Over 6 Month + 76.4%
  • Over 1 Year + 121.28%

Smart Investing Starts Here Start SIP with Sakar Healthcare for Steady Growth!

Invest Now

Sakar Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 50.9
  • PEG Ratio
  • 0.7
  • Market Cap Cr
  • 1,550
  • P/B Ratio
  • 4.9
  • Average True Range
  • 47.48
  • EPS
  • 13.7
  • Dividend Yield
  • 0
  • MACD Signal
  • 12.08
  • RSI
  • 66.87
  • MFI
  • 76.62

Sakar Healthcare Financials

Sakar Healthcare Technicals

EMA & SMA

Current Price
₹696.70
+ 96.9 (16.16%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹599.34
  • 50 Day
  • ₹564.72
  • 100 Day
  • ₹514.76
  • 200 Day
  • ₹454.47

Resistance and Support

664.37 Pivot Speed
  • R3 865.03
  • R2 787.37
  • R1 742.03
  • S1 619.03
  • S2 541.37
  • S3 496.03

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sakar Healthcare has an operating revenue of Rs. 251.74 Cr. on a trailing 12-month basis. An annual revenue growth of 42% is outstanding, Pre-tax margin of 16% is great, ROE of 9% is fair but needs improvement. The company has a reasonable debt to equity of 10%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 6% and 40% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 62 which is a FAIR score but needs to improve its earnings, a RS Rating of 94 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 26 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sakar Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-12 Audited results & Others To consider other business matters.
2026-02-05 Quarterly Results & Others To consider other business matters.
2025-11-07 Quarterly Results & Others To consider other business matters.
2025-07-25 Quarterly Results & Others To consider other business matters.
2025-05-15 Audited results

Sakar Healthcare Shareholding Pattern

52.86%
12.94%
18.12%
16.08%

Sakar Healthcare FAQs

Sakar Healthcare share price is ₹696 As on 17 May, 2026 | 13:32

The Market Cap of Sakar Healthcare is ₹1550.2 Cr As on 17 May, 2026 | 13:32

The P/E ratio of Sakar Healthcare is 50.9 As on 17 May, 2026 | 13:32

The PB ratio of Sakar Healthcare is 4.9 As on 17 May, 2026 | 13:32

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23